NSUN2 and breast cancer: IHC analyses showed that 54 of 60 (90.0%) ER-negative paraffin-embedded breast cancer tissue samples displayed moderate or strong NSUN2 nuclear staining, whereas 56 of 131 (42.7%) ER-positive tumor demonstrated a decreased rate of NSUN2 staining (P<0.001).